IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.
Anti-neutrophil cytoplasmic autoantibodies (ANCA) directed against myeloperoxidase (MPO) and proteinase 3 (Pr3) are considered pathogenic in ANCA-associated necrotizing and crescentic glomerulonephritis (NCGN) and vasculitis. Modulation of ANCA IgG glycosylation may potentially reduce its pathogenicity by abolishing Fc receptor-mediated activation of leukocytes and complement. Here, we investigated whether IgG hydrolysis by the bacterial enzyme endoglycosidase S (EndoS) attenuates ANCA-mediated NCGN. In vitro, treatment of ANCA IgG with EndoS significantly attenuated ANCA-mediated neutrophil activation without affecting antigen-binding capacity. In a mouse model of anti-MPO IgG/LPS-induced NCGN, we induced disease with either unmodified or EndoS-treated (deglycosylated) anti-MPO IgG. In separate experiments, we administered EndoS systemically after disease induction with unmodified anti-MPO IgG. Pretreatment of anti-MPO IgG with EndoS reduced hematuria, leukocyturia, and albuminuria and attenuated both neutrophil influx and formation of glomerular crescents. After inducing disease with unmodified anti-MPO IgG, systemic treatment with EndoS reduced albuminuria and glomerular crescent formation when initiated after 3 but not 24 hours. In conclusion, IgG glycan hydrolysis by EndoS attenuates ANCA-induced neutrophil activation in vitro and prevents induction of anti-MPO IgG/LPS-mediated NCGN in vivo. Systemic treatment with EndoS early after disease induction attenuates the development of disease. Thus, modulation of IgG glycosylation is a promising strategy to interfere with ANCA-mediated inflammatory processes.
van Timmeren
Mirjan M
MM
Departments of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands.
van der Veen
Betty S
BS
Stegeman
Coen A
CA
Petersen
Arjen H
AH
Hellmark
Thomas
T
Collin
Mattias
M
Heeringa
Peter
P
D000328:Adult; D000368:Aged; D000818:Animals; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000378:metabolism*; D001426:Bacterial Proteins / Q000494:pharmacology; D016022:Case-Control Studies; D004195:Disease Models, Animal; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced / Q000378:metabolism* / Q000517:prevention & control*; D006026:Glycoside Hydrolases / Q000494:pharmacology; D006801:Humans; D006868:Hydrolysis / Q000187:drug effects; D007074:Immunoglobulin G / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000009:adverse effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008875:Middle Aged; D009504:Neutrophils / Q000473:pathology; D009195:Peroxidase / Q000276:immunology; D011134:Polysaccharides / Q000378:metabolism*; D013997:Time Factors
D019268:Antibodies, Antineutrophil Cytoplasmic; D001426:Bacterial Proteins; D007074:Immunoglobulin G; D008070:Lipopolysaccharides; D011134:Polysaccharides; D009195:Peroxidase; D006026:Glycoside Hydrolases; C431325:NDOS protein, Streptococcus pyogenes
J Am Soc Nephrol. 1999 Jul;10(7):1506-15
10405206
Ann Rheum Dis. 1993 Feb;52(2):115-20
8383482
Nat Rev Immunol. 2008 Jan;8(1):34-47
18064051
Clin Exp Immunol. 1994 Nov;98(2):270-8
7955533
Clin Exp Immunol. 1991 Mar;83(3):379-86
1848489
Kidney Int. 2007 Apr;71(7):646-54
17299525
Infect Immun. 2001 Nov;69(11):7187-9
11598100
J Immunol. 1998 Dec 15;161(12):6909-14
9862724
Am J Pathol. 2007 Jan;170(1):52-64
17200182
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15005-9
18815375
Infect Immun. 1999 Apr;67(4):1828-36
10085024
Blood. 2005 Sep 15;106(6):2050-8
15933057
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4265-70
18332429
J Immunol. 1994 Aug 1;153(3):1271-80
8027554
Nephrol Dial Transplant. 2005 Jan;20(1):96-104
15546891
J Am Soc Nephrol. 1997 Mar;8(3):386-94
9071707
Eur J Immunol. 2007 Oct;37(10):2973-82
17899548
Am J Pathol. 2005 Jul;167(1):39-45
15972950
J Leukoc Biol. 2004 Dec;76(6):1162-70
15331626
Nephrology (Carlton). 2009 Feb;14(1):16-25
19335841
PLoS One. 2008 Jan 09;3(1):e1413
18183294
EMBO J. 2001 Jun 15;20(12):3046-55
11406581
J Am Soc Nephrol. 2008 May;19(5):973-84
18305123
Arthritis Rheum. 2009 May;60(5):1548-57
19404956
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4115-9
2161532
Kidney Int. 1990 Feb;37(2):799-806
2155342
J Biol Chem. 2004 May 21;279(21):22558-70
15028731
Am J Pathol. 2005 Jul;167(1):47-58
15972951
Curr Opin Immunol. 2008 Aug;20(4):471-8
18606225
Clin Exp Immunol. 2002 Jul;129(1):183-90
12100039
Trends Immunol. 2005 Nov;26(11):561-4
16139567
Am J Pathol. 2009 Apr;174(4):1212-20
19264905
Kidney Int. 1999 Nov;56(5):1751-8
10571783
Nat Clin Pract Rheumatol. 2006 Dec;2(12):661-70
17133251
J Clin Invest. 2002 Oct;110(7):955-63
12370273
Biochim Biophys Acta. 2006 Apr;1760(4):669-77
16413679
Best Pract Res Clin Rheumatol. 2009 Jun;23(3):391-401
19508946
Kidney Int. 2000 Jun;57(6):2195-206
10844589